Status:
COMPLETED
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
Lead Sponsor:
Eisai Co., Ltd.
Conditions:
Acute Gastritis
Gastric Ulcer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a self-controlled, open, multiple-center clinical trial.
Eligibility Criteria
Inclusion
- Inclusion criteria
- Age is over 18 years old , men or women
- Erosive lesions or flat lesions with thin white coating in acute gastritis, acute stage of chronic gastritis with over three lesions (including three lesions) by endoscopy prior to study in 3 days or diagnosed by clinical symptoms and signs;
- Signed the informed consent forms.
- Exclusion criteria
- Patients without inclusion criteria
- Patients with significant cardiovascular, pulmonary, hepatic, renal or hemopoietic system primary disease
- Patients with other digestive diseases.
- Patients with operation on stomach and duodenum.
- Patients administered with nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids
- Patients with severity trauma, surgery, infection and shock.
- Patients with any kind of tumor
- Women either pregnant or breast feeding
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
1184 Patients enrolled
Trial Details
Trial ID
NCT01190657
Start Date
May 1 2010
End Date
February 1 2013
Last Update
April 1 2013
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese People's Liberation Army General Hospital of Beijing Military
Beijing, China
2
Chongqing First People's Hospital
Chongqing, China
3
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, China
4
Wuhan Union Hospital
Hubei, China